WallStSmart

Haoxi Health Technology Limited (HAO)vsSpotify Technology SA (SPOT)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Spotify Technology SA generates 34207% more annual revenue ($18.81B vs $54.83M). SPOT leads profitability with a 15.7% profit margin vs -17.4%. SPOT earns a higher WallStSmart Score of 54/100 (C-).

HAO

Hold

49

out of 100

Grade: D+

Growth: 8.7Profit: 2.0Value: 5.0Quality: 9.0
Piotroski: 4/9Altman Z: 5.80

SPOT

Buy

54

out of 100

Grade: C-

Growth: 6.0Profit: 8.0Value: 3.3Quality: 8.0
Piotroski: 4/9Altman Z: 2.66
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for HAO.

SPOTSignificantly Overvalued (-51.5%)

Margin of Safety

-51.5%

Fair Value

$321.50

Current Price

$598.51

$277.01 premium

UndervaluedFair: $321.50Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HAO5 strengths · Avg: 10.0/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
137.3%10/10

Revenue surging 137.3% year-over-year

EPS GrowthGrowth
172.7%10/10

Earnings expanding 172.7% YoY

Debt/EquityHealth
0.0910/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
5.8010/10

Safe zone — low bankruptcy risk

SPOT4 strengths · Avg: 9.0/10
Debt/EquityHealth
0.0510/10

Conservative balance sheet, low leverage

Market CapQuality
$125.22B9/10

Large-cap with strong market position

Return on EquityProfitability
29.8%9/10

Every $100 of equity generates 30 in profit

Revenue GrowthGrowth
16.3%8/10

16.3% revenue growth

Areas to Watch

HAO4 concerns · Avg: 2.0/10
Market CapQuality
$695,6403/10

Smaller company, higher risk/reward

Return on EquityProfitability
-15.5%2/10

ROE of -15.5% — below average capital efficiency

Free Cash FlowQuality
$-301,8302/10

Negative free cash flow — burning cash

Profit MarginProfitability
-17.4%1/10

Currently unprofitable

SPOT4 concerns · Avg: 3.5/10
PEG RatioValuation
1.604/10

Expensive relative to growth rate

P/E RatioValuation
37.1x4/10

Premium valuation, high expectations priced in

Price/BookValuation
12.5x4/10

Trading at 12.5x book value

EPS GrowthGrowth
-24.5%2/10

Earnings declined 24.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : HAO

The strongest argument for HAO centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 137.3% demonstrates continued momentum.

Bull Case : SPOT

The strongest argument for SPOT centers on Debt/Equity, Market Cap, Return on Equity. Profitability is solid with margins at 15.7% and operating margin at 13.5%. Revenue growth of 16.3% demonstrates continued momentum.

Bear Case : HAO

The primary concerns for HAO are Market Cap, Return on Equity, Free Cash Flow.

Bear Case : SPOT

The primary concerns for SPOT are PEG Ratio, P/E Ratio, Price/Book.

Key Dynamics to Monitor

HAO profiles as a hypergrowth stock while SPOT is a growth play — different risk/reward profiles.

SPOT carries more volatility with a beta of 1.46 — expect wider price swings.

HAO is growing revenue faster at 137.3% — sustainability is the question.

SPOT generates stronger free cash flow (734M), providing more financial flexibility.

Bottom Line

SPOT scores higher overall (54/100 vs 49/100), backed by strong 15.7% margins and 16.3% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Haoxi Health Technology Limited

COMMUNICATION SERVICES · ADVERTISING AGENCIES · USA

Haoxi Health Technology Limited Class A Ordinary Shares is a pioneering force in the health technology sector, focused on revolutionizing healthcare through innovative, technology-driven solutions. The company harnesses advanced artificial intelligence and data analytics to enhance diagnostic precision, streamline treatment processes, and improve patient management. With a robust commitment to research and development, Haoxi is well-positioned to tackle emerging healthcare challenges, presenting substantial growth opportunities for institutional investors aiming to leverage advancements in this dynamic and rapidly evolving market.

Spotify Technology SA

COMMUNICATION SERVICES · INTERNET CONTENT & INFORMATION · USA

Spotify Technology SA, provides audio streaming services worldwide. The company is headquartered in Luxembourg, Luxembourg.

Want to dig deeper into these stocks?